Trintellix and Cognition: A Closer Look
The Carlat Psychiatry Report, Volume 17, Number 2, February 2019
Michael Posternak, MD.
Psychiatrist in private practice, Boston, MA
Dr. Posternak has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
You may have been hearing a lot of buzz about vortioxetine (Trintellix) and cognition. The FDA recently allowed a labeling change with this antidepressant that mentions specific benefits in cognitive symptoms of depression. Depressed patients tell us all the time how bad their memory is, and their concerns are valid.